A. Alsalloum

发表

TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors

J. Lopatnikova, J. Shevchenko, A. Silkov, 2023, Biomedicines.

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4

J. Lopatnikova, S. Sennikov, J. Shevchenko, 2023, International journal of molecular sciences.

NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy

J. Shevchenko, S. Sennikov, A. Alsalloum, 2024, Clinical and translational medicine.

The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?

S. Sennikov, J. Shevchenko, Alaa Alsalloum, 2023, Cancers.

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

J. Lopatnikova, J. Shevchenko, A. Silkov, 2024, Cancers.